Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori.

Background: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants.